FUSION PHARMACEUTICALS INC
COM · CUSIP 36118A100 · ISIN CA36118A1003
0
institutional holders
-115 vs Q1 2024
—reported value*
0 new
0 added
0 reduced
113 sold out
net sold ≈ $1.5bn (-70.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 35 |
| Q4 2022 | 31 |
| Q1 2023 | 39 |
| Q2 2023 | 42 |
| Q3 2023 | 42 |
| Q4 2023 | 78 |
| Q1 2024 | 115 |
| Q2 2024 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 7 | 9 |
| Q1 2023 | 18 | 9 |
| Q2 2023 | 15 | 8 |
| Q3 2023 | 11 | 12 |
| Q4 2023 | 55 | 12 |
| Q1 2024 | 90 | 40 |
| Q2 2024 | 0 | 113 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $0 | $0 | — |
| Q4 2023 | $591.9k | $172.0k | 0.29 |
| Q1 2024 | $51.3m | $87.5m | 1.71 |
| Q2 2024 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| FEDERATED HERMES, INC. | Sold out | -10.8m |
| PERCEPTIVE ADVISORS LLC | Sold out | -6.8m |
| Avidity Partners Management LP | Sold out | -6.5m |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Sold out | -6.4m |
| FIL Ltd | Sold out | -4.2m |
| Pentwater Capital Management LP | Sold out | -3.8m |
| JOHNSON & JOHNSON | Sold out | -3.7m |
| CANADA PENSION PLAN INVESTMENT BOARD | Sold out | -3.1m |
| TPG GP A, LLC | Sold out | -2.6m |
| FMR LLC | Sold out | -1.8m |
Holders, Q2 2024
| Manager | Shares | Change |
|---|